TrialCancer chemotherapy and pharmacology2020

A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers.

Donghoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.